Target intelligence / Profile preview

Multiple pro-inflammatory pathways

Molecular classification
Other
01

Overview

Multiple pro-inflammatory pathways refer to the integrated network of intracellular and extracellular signaling cascades that drive the body's response to injury, infection, or stress (Medzhitov, 2008, Nature). Key pathways within this category include the Nuclear Factor-kappa B (NF-κB) system, the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, and various Mitogen-Activated Protein Kinase (MAPK) cascades (Oeckinghaus & Ghosh, 2009, Cold Spring Harb Perspect Biol; Hu et al., 2021, Signal Transduct Target Ther). These pathways are activated by stimuli such as Toll-like receptor (TLR) ligands or pro-inflammatory cytokines, leading to the transcription of genes that promote inflammation and immune cell recruitment. While essential for host defense, chronic or dysregulated activation of these pathways is a primary driver of autoimmune diseases, chronic inflammatory conditions, and the tumor microenvironment in cancer (Arthur & Ley, 2013, Nat Rev Immunol). Therapeutic interventions often target specific components of these pathways, such as JAK inhibitors or TNF-alpha blockers, to reduce pathological inflammation. However, because these pathways are also critical for normal physiological processes, broad inhibition can lead to significant safety concerns, most notably an increased susceptibility to opportunistic infections.

Other names
Inflammatory signaling cascadesPro-inflammatory signalingCytokine signaling pathwaysInflammatory response pathways
02

Mechanism of action

Inhibition of multiple signaling nodes including kinases (JAK, MAPK), transcription factors (NF-κB), and cytokine receptors to suppress the coordinated inflammatory response.

03

Biological functions

Immune responseSignal transductionCell proliferationApoptosisCytokine production
04

Disease associations

InflammationAutoimmune diseaseCancerCardiovascular diseaseNeurodegenerative diseaseInfection
05

Safety considerations

Systemic immunosuppressionIncreased risk of serious infectionsReactivation of latent tuberculosisImpaired wound healingPotential for malignancy with long-term use
06

Interacting drugs

Prednisone

7 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Erythrocyte sedimentation rate (ESR)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-α)Interleukin-1 beta (IL-1β)

Beyond the preview

Go deeper on Multiple pro-inflammatory pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple pro-inflammatory pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call